Abdel-Al A, El-Ahwany E, Zoheiry M, Hassan M, Ouf A, Abu-Taleb H et al (2018) miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Res 253:135–139

Article  PubMed  Google Scholar 

Abdulrahman GO, Rahman GA (2012) Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol (1):915610

Affo S, Yu L-X, Schwabe RF (2017) The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol 12:153

Article  PubMed  Google Scholar 

Afra F, Mahboobipour AA, Farid AS, Ala M (2023) Recent progress in the immunotherapy of hepatocellular carcinoma: non-coding RNA-based immunotherapy may improve the outcome. Biomed Pharmacother 165:115104

Article  PubMed  Google Scholar 

Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat C-H et al (2016) MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep 6:34935

Article  PubMed  PubMed Central  Google Scholar 

Baglieri J, Brenner DA, Kisseleva T (2019) The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int J Mol Sci 20(7):1723

Article  PubMed  PubMed Central  Google Scholar 

Bandiera S, Pfeffer S, Baumert TF, Zeisel MB (2015) miR-122–a key factor and therapeutic target in liver disease. J Hepatol 62(2):448–457

Article  PubMed  Google Scholar 

Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A et al (2014) Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer 14(1):721

Article  PubMed  PubMed Central  Google Scholar 

Bao H, Jiang K, Meng K, Liu W, Liu P, Du Y, Wang D (2018) TGF-β2 induces proliferation and inhibits apoptosis of human tenon capsule fibroblast by miR-26 and its targeting of CTGF. Biomed Pharmacother 104:558–565

Article  PubMed  Google Scholar 

Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q et al (2017) Serum MicroRNA levels as a Noninvasive Diagnostic Biomarker for the early diagnosis of Hepatitis B Virus-related liver fibrosis. Gut Liver 11(6):860

Article  PubMed  PubMed Central  Google Scholar 

Barcena-Varela M, Colyn L, Fernandez-Barrena MG (2019) Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis. Int J Mol Sci 20(10):2507

Article  PubMed  PubMed Central  Google Scholar 

Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Investig 115(2):209–218

Article  PubMed  PubMed Central  Google Scholar 

Bitto N, Liguori E, Mura VL (2018) Coagulation, microenvironment and liver fibrosis. Cells 7(8):85

Article  PubMed  PubMed Central  Google Scholar 

Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S et al (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30(47):4750–4756

Article  PubMed  PubMed Central  Google Scholar 

Brea R, Motiño O, Francés D, García-Monzón C, Vargas J, Fernández-Velasco M et al (2018) PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p. Biochim Biophys Acta Mol Basis Dis 1864(2):325–337

Article  PubMed  Google Scholar 

Bu F-t, Zhu Y, Chen X, Wang A, Zhang Y-f, You H-m et al (2021) Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis. Mol Therapy-Nucleic Acids 23:847–862

Article  Google Scholar 

Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205

Article  PubMed  Google Scholar 

Cai Y, Huang G, Ma L, Dong L, Chen S, Shen X et al (2018) Smurf2, an E3 ubiquitin ligase, interacts with PDE4B and attenuates liver fibrosis through miR-132 mediated CTGF inhibition. Biochim Biophys Acta Mol Cell Res 1865(2):297–308

Article  PubMed  Google Scholar 

Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K et al (2014) Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59(3):1118–1129

Article  PubMed  Google Scholar 

Chen G, Liu M, Jiang Z, Yu M, Wei S (2016) MicroRNAs play significant roles in Pathogenesis of HBV-Related diseases. J Biomed Sci Eng 9(10):78

Article  Google Scholar 

Chen R, Wu JC, Liu T, Qu Y, Lu LG, Xu MY (2017) Micro RNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients. J Dig Dis 18(2):115–124

Article  PubMed  Google Scholar 

Chen Y, Yuan B, Wu Z, Dong Y, Zhang L, Zeng Z (2017) Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation. Gene 629:35–42

Article  PubMed  Google Scholar 

Chen W, Lin C, Gong L, Chen J, Zeng P, Diao H (2019) Comprehensive analysis of the mRNA-lncRNA co-expression profile and ceRNA networks patterns in chronic hepatitis B. Curr Genom 20(4):231–245

Article  Google Scholar 

Chen X, Li H-D, Bu F-T, Li X-F, Chen Y, Zhu S et al (2020) Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics 10(11):4851

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Yuan B, Chen G, Zhang L, Zhuang Y, Niu H, Zeng Z (2020) Circular RNA RSF1 promotes inflammatory and fibrotic phenotypes of irradiated hepatic stellate cell by modulating miR-146a‐5p. J Cell Physiol 235(11):8270–8282

Article  PubMed  Google Scholar 

Chen W, Jiang J, Gong L, Shu Z, Xiang D, Zhang X et al (2021) Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis. J Experimental Clin Cancer Res 40:1–18

Article  Google Scholar 

Cheng J-L, Zhao H, Yang S-G, Chen E-M, Chen W-Q, Li L-J (2018) Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT. Hep Intl 12(3):1–11

Article  Google Scholar 

Cheng D, Deng J, Zhang B, He X, Meng Z, Li G et al (2018) LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine 36:159–170

Article  PubMed  PubMed Central  Google Scholar 

Chien Y, Tsai P-H, Lai Y-H, Lu K-H, Liu C-Y, Lin H-F et al (2020) CircularRNA as novel biomarkers in liver diseases. J Chin Med Association 83(1):15–17

Article  Google Scholar 

Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y et al (2006) Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Hepatology 44(5):1267–1277

Article  PubMed  Google Scholar 

Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL et al (2008) Elevated expression of the miR-17–92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173(3):856–864

Article  PubMed  PubMed Central  Google Scholar 

Cuiqiong W, Chao X, Xinling F, Yinyan J (2020) Schisandrin B suppresses liver fibrosis in rats by targeting mir-101-5p through the TGF-β signaling pathway. Artif Cells Nanomed Biotechnol 48(1):473–478

Article  PubMed  Google Scholar 

D’souza S, Lau KC, Coffin CS, Patel TR (2020) Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 26(38):5759

Article  PubMed  PubMed Central  Google Scholar 

Dai X, Chen C, Xue J, Xiao T, Mostofa G, Wang D et al (2019) Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Toxicol Lett 316:73–84

Article  PubMed  Google Scholar 

Dasgupta I, Chatterjee A (2021) Recent advances in miRNA delivery systems. Methods Protocols 4(1):10

Article  PubMed  PubMed Central  Google Scholar 

Dhar D, Baglieri J, Kisseleva T, Brenner DA (2020) Mechanisms of liver fibrosis and its role in liver cancer. Experimental Biology Med 245(2):96–108